Antipsychotic dosing: how much but also how often?

Area of Science:

• Pharmacology
• Psychiatry
• Clinical Therapeutics

Background:

• Current clinical practice emphasizes continuous antipsychotic exposure to maintain steady-state levels and prevent relapse.
• Antipsychotic nonadherence and discontinuation are recognized risks for patient relapse.
• The optimal frequency of antipsychotic administration remains unclear, despite focus on dosage.

Purpose of the Study:

• To question the established clinical axiom of daily antipsychotic administration.
• To explore the evidence challenging the necessity of at least daily antipsychotic dosing.
• To investigate alternative administration frequencies for antipsychotic medications.

Main Methods:

• Review of existing clinical evidence and pharmacological data.
• Analysis of studies examining antipsychotic relapse rates and adherence.
• Examination of pharmacokinetic principles related to antipsychotic drug levels.

Main Results:

• A growing body of evidence suggests that daily administration may not be a strict requirement for antipsychotic effectiveness.
• The assumption of needing daily dosing to prevent relapse is being challenged by research findings.
• Alternative dosing frequencies might be viable without compromising therapeutic outcomes.

Conclusions:

• The long-established practice of administering antipsychotics daily warrants re-evaluation.
• Further research is needed to establish optimal, potentially less frequent, antipsychotic administration schedules.
• Clinical guidelines may need to adapt based on emerging evidence regarding antipsychotic dosing frequency.